Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-10-05

Clinical Trial Update: TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating chondroitin sulfate for knee osteoarthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chondroitin sulfate (chondroitin sulfate)

Snippet

Sponsor: IBSA Institut Biochimique SA | Conditions: Knee Osteoarthritis | Phase 3 | Status: WITHDRAWN